Skip to content

The effect of davayebalgham capsule and acupuncture on type 2 diabetic patients

The effect of davayebalgham capsule (a Persian medicine product) and acupuncture on blood sugar and lipid profile of type 2 diabetic patients (a randomized clinical study)

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220502054721N1
Enrollment
105
Registered
2022-10-22
Start date
2022-07-23
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes. Type 2 diabetes mellitus

Interventions

Intervention 1: Intervention group: Davaebalgham product. After the raw materials of this formulation including mastic gum, Trachyspermum ammi (L.) Sprague, Nigella sativa L and Zataria multiflora Boi

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Type 2 Diabetes patients Taking oral hypoglycemic drugs Age 20-65 years Satisfaction to enter the plan HbA?C < %?

Exclusion criteria

Exclusion criteria: Having serious gastrointestinal diseases including active stomach ulcers and gastrointestinal bleeding History of diabetic ketoacidosis, non-ketone hyperosmolar diabetic coma, severe infection or surgery in the previous month Kidney failure, liver dysfunction, cancers, cysts or breast mass, metabolic diseases Having a psychological illness Consumption of alcohol, drugs or psychotropic substances Uncontrolled hypertension (blood pressure greater than or equal to 100/160 mm Hg) History of myocardial infarction Taking anticoagulants (warfarin and Plavix ...) Insulin therapy over the past three months Continued use of herbs or other herbal medicines Fasting blood sugar above 180 Pregnancy, breastfeeding Having allergies to any of the plants

Design outcomes

Primary

MeasureTime frame
Fasting blood sugar. Timepoint: The beginning of the study, 3 months later. Method of measurement: laboratory kit.;Blood cholesterol. Timepoint: The beginning of the study, 3 months later. Method of measurement: Laboratory kit (blood test).;Blood triglycerides. Timepoint: The beginning of the study, 3 months later. Method of measurement: Laboratory kit (blood test).

Secondary

MeasureTime frame
HbA?C. Timepoint: The beginning of the study, 3 months later. Method of measurement: Laboratory kit (blood test).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Rahimzade

Tehran University of Medical Sciences

m-rahimzade@razi.tums.ac.ir+98 21 8897 4535

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026